Genprex Revenue vs. Net Income
| GNPX Stock | USD 2.20 0.20 10.00% |
Total Revenue | First Reported 2015-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 4 K |
For Genprex profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Genprex to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Genprex utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Genprex's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Genprex over time as well as its relative position and ranking within its peers.
Check out Risk vs Return Analysis. Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genprex. If investors know Genprex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genprex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Genprex is measured differently than its book value, which is the value of Genprex that is recorded on the company's balance sheet. Investors also form their own opinion of Genprex's value that differs from its market value or its book value, called intrinsic value, which is Genprex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genprex's market value can be influenced by many factors that don't directly affect Genprex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genprex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genprex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genprex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Genprex Net Income vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Genprex's current stock value. Our valuation model uses many indicators to compare Genprex value to that of its competitors to determine the firm's financial worth. Genprex is currently under evaluation in revenue category among its peers. It is rated below average in net income category among its peers . At this time, Genprex's Total Revenue is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genprex's earnings, one of the primary drivers of an investment's value.Genprex Revenue vs. Competition
Genprex is currently under evaluation in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 39.17 Million. Genprex adds roughly 0.0 in revenue claiming only tiny portion of equities under Health Care industry.
Genprex Net Income vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Genprex |
| = | null |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Genprex |
| = | (21.11 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Genprex Net Income Comparison
Genprex is currently under evaluation in net income category among its peers.
Genprex Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Genprex, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Genprex will eventually generate negative long term returns. The profitability progress is the general direction of Genprex's change in net profit over the period of time. It can combine multiple indicators of Genprex, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -19.1 M | -20 M | |
| Net Loss | -19 M | -20 M | |
| Income Before Tax | -19 M | -20 M | |
| Total Other Income Expense Net | 72.5 K | 45 K | |
| Net Loss | -17.6 M | -16.8 M | |
| Net Loss | -19 M | -20 M | |
| Income Tax Expense | -19.2 B | -18.3 B | |
| Net Interest Income | 73.1 K | 58.6 K | |
| Interest Income | 73.1 K | 64 K | |
| Non Operating Income Net Other | 21.6 K | 18.5 K | |
| Change To Netincome | 5.4 M | 3.7 M | |
| Net Loss | -307 K | -291.6 K | |
| Income Quality | 0.73 | 0.54 | |
| Net Income Per E B T | 911.81 | 957.40 |
Genprex Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Genprex. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Genprex position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Genprex's important profitability drivers and their relationship over time.
Genprex Earnings Estimation Breakdown
The calculation of Genprex's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Genprex is estimated to be 0.0 with the future projection ranging from a low of 0.0 to a high of 0.0. Please be aware that this consensus of annual earnings estimates for Genprex is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.00 Lowest | Expected EPS | 0.00 Highest |
Genprex Earnings Projection Consensus
Suppose the current estimates of Genprex's value are higher than the current market price of the Genprex stock. In this case, investors may conclude that Genprex is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Genprex's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 1 | 56.44% | -5.0 | 0.0 | 42.5 |
Genprex Earnings per Share Projection vs Actual
Actual Earning per Share of Genprex refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Genprex predict the company's earnings will be in the future. The higher the earnings per share of Genprex, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Genprex Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Genprex, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Genprex should always be considered in relation to other companies to make a more educated investment decision.Genprex Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Genprex's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-11-14 | 2025-09-30 | -0.65 | -5.0 | -4.35 | 669 | ||
2025-08-14 | 2025-06-30 | -0.74 | -8.47 | -7.73 | 1044 | ||
2025-05-13 | 2025-03-31 | -2.54 | -0.26 | 2.28 | 89 | ||
2025-03-31 | 2024-12-31 | -0.39 | -0.4242 | -0.0342 | 8 | ||
2024-11-12 | 2024-09-30 | -1.93 | -1.23 | 0.7 | 36 | ||
2024-08-09 | 2024-06-30 | -2.3 | -3.0 | -0.7 | 30 | ||
2024-05-15 | 2024-03-31 | -2.54 | -3.69 | -1.15 | 45 | ||
2024-02-26 | 2023-12-31 | -3.93 | -3.96 | -0.03 | 0 | ||
2023-11-14 | 2023-09-30 | -0.11 | -0.13 | -0.02 | 18 | ||
2023-08-21 | 2023-06-30 | -0.12 | -0.15 | -0.03 | 25 | ||
2023-05-22 | 2023-03-31 | -0.12 | -0.19 | -0.07 | 58 | ||
2023-03-31 | 2022-12-31 | -0.15 | -0.13 | 0.02 | 13 | ||
2022-11-14 | 2022-09-30 | -0.12 | -0.13 | -0.01 | 8 | ||
2022-08-12 | 2022-06-30 | -0.12 | -0.11 | 0.01 | 8 | ||
2022-05-13 | 2022-03-31 | -0.12 | -0.12 | 0.0 | 0 | ||
2022-03-30 | 2021-12-31 | -0.09 | -0.12 | -0.03 | 33 | ||
2021-11-15 | 2021-09-30 | -0.11 | -0.07 | 0.04 | 36 | ||
2021-08-13 | 2021-06-30 | -0.13 | -0.08 | 0.05 | 38 | ||
2021-05-17 | 2021-03-31 | -0.12 | -0.14 | -0.02 | 16 | ||
2021-03-26 | 2020-12-31 | -0.28 | -0.14 | 0.14 | 50 | ||
2020-11-12 | 2020-09-30 | -0.21 | -0.07 | 0.14 | 66 | ||
2020-08-11 | 2020-06-30 | -0.13 | -0.12 | 0.01 | 7 | ||
2020-05-14 | 2020-03-31 | -0.08 | -0.2 | -0.12 | 150 | ||
2019-11-14 | 2019-09-30 | -0.22 | -0.15 | 0.07 | 31 | ||
2019-08-13 | 2019-06-30 | -0.21 | -0.24 | -0.03 | 14 | ||
2019-05-15 | 2019-03-31 | -0.2 | -0.14 | 0.06 | 30 | ||
2019-03-29 | 2018-12-31 | -0.14 | -8.0 | -7.86 | 5614 | ||
2018-11-14 | 2018-09-30 | -0.13 | -0.15 | -0.02 | 15 | ||
2018-08-14 | 2018-06-30 | -0.17 | -0.31 | -0.14 | 82 | ||
2017-10-10 | 2017-09-30 | 0 | -0.07 | -0.07 | 0 | ||
2017-07-21 | 2017-06-30 | 0 | -0.05 | -0.05 | 0 |
Use Genprex in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genprex position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genprex will appreciate offsetting losses from the drop in the long position's value.Genprex Pair Trading
Genprex Pair Trading Analysis
The ability to find closely correlated positions to Genprex could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genprex when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genprex - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genprex to buy it.
The correlation of Genprex is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genprex moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genprex moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genprex can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Genprex position
In addition to having Genprex in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Processed Foods Thematic Idea Now
Processed Foods
Companies producing and distributing processed foods to retail sectors. The Processed Foods theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Processed Foods Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Genprex Stock Analysis
When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.